Colorectal Polyp Prevention Support Protocol

Gastrointestinal HealthModerate Evidence
9
supplements
2
Primary
7
Supporting
0
Grade A
100
Studies

Primary Stack

Core supplements with strongest evidence
1000-1200mg daily with food

Binds bile acids and fatty acids in colon; reduces cell proliferation; studied for polyp recurrence prevention

15 studies3,000 participants
2000-4000 IU daily (maintain levels 40-60 ng/mL)

May enhance calcium's protective effects; anti-proliferative effects on colon cells; deficiency linked to increased risk

15 studies2,500 participants

Supporting Stack

Additional supplements for enhanced results
25-35g total fiber daily from food and supplements

Increases stool bulk; reduces transit time; dilutes carcinogens; produces beneficial short-chain fatty acids

20 studies5,000 participants
2-4g EPA+DHA daily

Anti-inflammatory; may reduce COX-2 and prostaglandins in colon; studied for polyp prevention

10 studies800 participants
400-800mcg methylfolate daily (from food preferred)

Supports DNA synthesis and repair; deficiency may increase colorectal cancer risk; complex relationship

12 studies1,000 participants
10-20 billion CFU daily (multi-strain)

Supports healthy gut microbiome; may produce protective short-chain fatty acids; emerging area

8 studies500 participants
500-2000mg daily with enhanced absorption

Anti-inflammatory; laboratory studies show effects on colorectal cancer cells; limited human trial data

8 studies300 participants
300-400mg EGCG daily

Polyphenols with anti-cancer properties; studied for colorectal adenoma prevention

6 studies400 participants
100-200mcg daily

Antioxidant; some observational data suggest lower colorectal cancer risk with adequate selenium

6 studies400 participants

How This Protocol Works

Simple Explanation

Colorectal polyps are growths on the inner lining of the colon or rectum. While most polyps are benign, some types (adenomatous polyps or adenomas) can develop into colorectal cancer over time. Removing polyps during colonoscopy prevents cancer.

TYPES OF POLYPS:

•Adenomatous (adenomas): Can become cancerous; need removal and follow-up
•Hyperplastic: Usually not precancerous; small ones often left alone
•Sessile serrated: Precancerous; require careful surveillance
•Inflammatory: Related to IBD; not typically precancerous

SCREENING SAVES LIVES:

•Colonoscopy starting at age 45 (earlier if high risk)
•Removes polyps before they become cancer
•Follow surveillance intervals based on findings

LIFESTYLE FACTORS that reduce polyp risk:

•High-fiber diet (vegetables, fruits, whole grains)
•Limit red and processed meat
•Limit alcohol
•Maintain healthy weight
•Regular physical activity
•Don't smoke

MEDICATIONS sometimes used:

•Low-dose aspirin (discuss with doctor - bleeding risk)
•NSAIDs reduce polyp risk but have side effects

* Calcium with Vitamin D has the strongest evidence for reducing adenoma recurrence.

* Fiber supports healthy colon function and may reduce risk.

* Omega-3 Fatty Acids have anti-inflammatory effects that may help prevent polyps.

Expected timeline: Prevention is a long-term commitment. Studies showing benefit typically follow patients for 3-5 years. Regular colonoscopy surveillance is essential regardless of supplement use.

Clinical Perspective

Colorectal Polyps: Adenomatous polyps (adenomas) are precursors to colorectal cancer; adenoma-carcinoma sequence takes 10-15 years. Types: tubular, tubulovillous, villous (highest malignant potential). Risk factors: age, family history, IBD, Lynch syndrome, FAP. Surveillance: based on polyp number, size, histology, family history; intervals 3-10 years. Screening: colonoscopy recommended starting age 45 (USPSTF 2021).

CRITICAL: Colonoscopy with polypectomy is definitive prevention. Surveillance intervals must be followed. Lifestyle modification (diet, weight, exercise, no smoking) has strongest evidence. Supplements may provide additional benefit but do not replace screening. Low-dose aspirin may be recommended for some - discuss with physician.

* Calcium (B-grade): Bile acid binding; cell proliferation. Systematic review: (PMID: 26443622). Meta-analysis: (PMID: 29049439). 1000-1200mg daily.

* Vitamin D (B-grade): Synergy with calcium; anti-proliferative. Meta-analysis: (PMID: 28750270). 2000-4000 IU daily. Target 40-60 ng/mL.

* Fiber (B-grade): Stool bulk; short-chain fatty acids. Meta-analysis: (PMID: 25623152). 25-35g daily.

* Omega-3 Fatty Acids (B-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.

* Folate (C-grade): DNA repair; complex relationship. Systematic review: (PMID: 27450775). 400-800mcg daily. Food sources preferred.

* Probiotics (C-grade): Microbiome; SCFA. Review: (PMID: 29882905). Multi-strain daily.

* Curcumin (C-grade): Anti-inflammatory. Review: (PMID: 25282711). 500-2000mg daily.

* Green Tea (C-grade): Polyphenols. Trial: (PMID: 26440377). 300-400mg EGCG daily.

* Selenium (C-grade): Antioxidant. Meta-analysis: (PMID: 28558777). 100-200mcg daily.

Assessment targets: Colonoscopy findings, adenoma recurrence, dietary habits, weight, vitamin D levels.

Protocol notes: Surveillance intervals: 1-2 adenomas <10mm = 7-10 years; 3-4 adenomas <10mm or any adenoma >=10mm = 3 years; 5-10 adenomas = 3 years; >10 adenomas = 1 year. High-risk: Lynch syndrome (1-2 year colonoscopy), FAP (colectomy usually needed). Aspirin: USPSTF recommends for cardiovascular prevention; may also reduce CRC risk; bleeding risk must be weighed. Red meat: limit to <3 servings/week; processed meat associated with increased risk. Alcohol: limit to 1 drink/day women, 2/day men. Obesity: increases risk; weight loss beneficial. Exercise: 30+ min moderate activity most days. Smoking: cessation reduces risk. Folate: adequate intake protective; high-dose supplements may be harmful if existing adenoma/cancer. Calcium: food sources preferred; supplements may increase cardiovascular risk in some. Family history: first-degree relative with CRC = earlier and more frequent screening. IBD: increased risk; surveillance colonoscopy with biopsies.